S&P 500
(0.06%) 5 251.78 points
Dow J
(0.01%) 39 766 points
Nasdaq
(-0.11%) 16 382 points
Oil
(2.00%) $82.98
Gas
(1.51%) $1.744
Gold
(1.18%) $2 238.90
Silver
(0.73%) $24.93
Platinum
(1.27%) $921.25
USD/EUR
(0.30%) $0.926
USD/NOK
(0.75%) $10.85
USD/GBP
(0.10%) $0.792
USD/RUB
(0.14%) $92.57

Realtime updates for Kura Oncology Inc [KURA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
80.00%
return 6.18%
SELL
0.00%
return 10.19%
Last Updated28 Mar 2024 @ 13:39

1.32% $ 21.45

BUY 61734 min ago

@ $19.65

Issued: 14 Feb 2024 @ 15:45


Return: 9.16%


Previous signal: Feb 14 - 09:30


Previous signal: Sell


Return: -2.04 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 13:39):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer...

Stats
Today's Volume 187 893
Average Volume 1.48M
Market Cap 1.63B
EPS $0 ( 2024-02-27 )
Next earnings date ( $-0.560 ) 2024-05-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -10.31
ATR14 $0.0220 (0.10%)
Insider Trading
Date Person Action Amount type
2024-01-29 Doyle Thomas James Sell 594 Common Stock
2024-01-29 Doyle Thomas James Sell 761 Common Stock
2024-01-29 Doyle Thomas James Sell 963 Common Stock
2024-01-29 Bair Teresa Brophy Sell 2 053 Common Stock
2024-01-29 Ford Kathleen Sell 1 496 Common Stock
INSIDER POWER
40.80
Last 95 transactions
Buy: 6 371 376 | Sell: 2 723 562

Volume Correlation

Long: 0.10 (neutral)
Short: 0.93 (very strong)
Signal:(39.953) Expect same movement, but be aware

Kura Oncology Inc Correlation

10 Most Positive Correlations
RMRM0.943
GAINL0.888
LQDT0.876
TRVN0.857
SLNH0.85
QTEK0.834
SWVL0.825
HYMC0.824
VYNT0.817
LITM0.808
10 Most Negative Correlations
FANH-0.844

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kura Oncology Inc Correlation - Currency/Commodity

The country flag -0.20
( neutral )
The country flag -0.05
( neutral )
The country flag 0.00
( neutral )
The country flag -0.16
( neutral )
The country flag 0.55
( weak )
The country flag -0.21
( neutral )

Kura Oncology Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-849 000 (0.00 %)
EPS: $-2.08
Q4 2023
Revenue: $1.27M
Gross Profit: $1.06M (83.15 %)
EPS: $-0.550
Q3 2023
Revenue: $0
Gross Profit: $-216 000 (0.00 %)
EPS: $-0.500
Q2 2023
Revenue: $0
Gross Profit: $-213 000 (0.00 %)
EPS: $-0.530

Financial Reports:

No articles found.

Kura Oncology Inc

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators